Subscribe



Latest Headlines

Thu 22 Feb 18

PD breaking news – Blackmores H1 profit up 20%


Pharmacy Daily

Blackmores H1 profit up 20%Blackmores has reported overall group revenue was boosted 9% to $287m for the six months to 31 Dec primarily from “consistent sales growth with improved profitability” and resulting in net profit after tax for shareholders at $34m, up 20% on the previous corresponding period.Revenue in Australia and New Zealand was $121m, slightly down from the previous year as the broader consumer market remained subdued and China-influenced sales continued to move to Blackmores’ direct China channels, directors said.


Thu 22 Feb 18

‘War’ not ‘jaw’ over code


Pharmacy Daily

IN AN unflinchingly direct letter to the Department of Health First Assistant Secretary Ross Hawkins, Friends of Science advocate and public health protagonist Associate Professor Ken Harvey of Monash University has called for "respect and constructive outcomes".


Thu 22 Feb 18

Community pharmacy tick


Pharmacy Daily

THE Australian "tried and trusted community pharmacy model" received a shot in the arm with the passage through Federal Parliament last week of amendments that removed the sunset clause on the Pharmacy Location Rules (PD 14 Feb), Pharmacy Guild of Australia executive director David Quilty writes.


Wed 21 Feb 18

CW nets major partnership


AUSTRALIAN pharmacy discount retail group Chemist Warehouse has again linked with Beach Netball ("It's netball, but not as you know it") as a major partner and is gearing up to support the upcoming 2018 series across the country.


Wed 21 Feb 18

EBOS H1 earnings up 15.6%


Pharmacy Daily

ASX-LISTED marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products EBOS, has announced a record interim unaudited net profit of $76.7m for the six months to 31 Dec 2017, with EBITDA up 15.6% and net profit after tax up 11.5%.


Wed 21 Feb 18

Gabapentinoid abuse up


THE US Food and Drug Administration (FDA) is actively looking into the potential misuse and abuse of gabapentinoids, a class of drugs that includes Pfizer's Neurontin (gabapentin) and Lyrica (pregabalin), which have been approved to treat a number of conditions such as postherpetic neuralgia, fibromyalgia and neuropathic pain.


Tue 20 Feb 18

TGA CM advertising debate


Pharmacy Daily

BOTH science and civil society organisations have continued to raise a storm over the passage through parliament the 2017 Measures No.1 Bill, according to an MJA Insight article.


Tue 20 Feb 18

Pharmacy training offers


THE Pharmaceutical Society of Australia (PSA) has announced it has resumed training for community pharmacy qualifications across Australia for pharmacy staff, including dispensary and pharmacy assistants.


Mon 19 Feb 18

‘Pharmacy first’ says NHS


Pharmacy Daily

PARENTS of young children with minor illnesses should take them to pharmacies rather than GPs or an A&E, a new NHS England campaign says, reports the BBC.


Mon 19 Feb 18

Med cannabis challenges


WITH society's growing demand for access to medicinal cannabis, physicians and regulators are facing "significant challenges" keeping pace, according to Royal Australasian College of Physicians (RACP) authors writing in the MJA.


View More Pharmacy News Subscribe to the Newsletter